Labor PainNCT03461640
Community Based Doulas for Migrant Women in Labour and Birth in Sweden - a Randomised Controlled Trial
A study testing Community-based doula support for labour and Standard labour support in people with Labor Pain and Satisfaction, Consumer, run by Karolinska Institutet at 1 site in Sweden.
Trial summary
One initiative to address communication problems between migrant women not fluent in Swedish and caregivers throughout childbirth is to provide language assistance, cultural interpretation and labour support to the woman through Community Based Doulas (CBDs). Read more about this study
- Who is it for?
- Ages 18 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- Labor Pain, Satisfaction, Consumer, Language
- What is being tested?
- Community-based doula support for labour and Standard labour support
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 164 participants
- Where
- 1 siteSweden
- Study dates
- 10 Mar 2018to 5 May 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Nulliparous and multiparous pregnant women
- 25-36 weeks gestation
- Somali-, Arabic-, Russian- or Tigrinya-speaking
- Cannot communicate fluently in Swedish
- No contra-indications for vaginal birth
Who cannot join
- Planned caesarean birth
- Not consenting to access to their birth records
- 17 years old or younger
Trial locations and contacts
1 site in 1 country.
About this study
One initiative to address communication problems between migrant women not fluent in Swedish and caregivers throughout childbirth is to provide language assistance, cultural interpretation and labour support to the woman through Community Based Doulas (CBDs). CBDs are bilingual women from migrant communities trained by midwives to provide cultural, language and labour support to migrant women throughout their labour and birth.
The study will evaluate the effectiveness of community-based doula support for improving the intrapartum care experiences and postnatal wellbeing of Somali-, Tigrinya -, Arabic- and Russian-speaking migrant women giving birth in Stockholm, Sweden.
Read more
The randomisation ratio will be 1:1; CBD support in addition to standard intrapartum care or standard intrapartum care. Women allocated to receive CBD support in addition to standard intrapartum care (intervention group), will be contacted by a Somali, Arabic-, Russian- or Tigrinya-speaking CBD as appropriate, and arrangements will be made for the doula and the women to meet twice prior to the birth to get to know each other and discuss the woman's wishes regarding support in labour and what the CBD can offer. Each woman will then contact her CBD when she goes into labour and the CBD will attend hospital with her and stay with her throughout labour and birth, in addition to any other support people she may have, such as her partner. Women allocated to the comparison arm of the trial will receive standard intrapartum care as provided at their chosen hospital of birth.
The hypothesis is that women randomised to receive CBD support in labour will rate their care for labour and birth more highly and have better emotional wellbeing (lower mean scores on the Edinburgh Postnatal Depression Scale) two months after birth than women allocated to standard care.
Read the detailed description
In Sweden, the proportion of births to migrant women has more than doubled over the last four decades, from 10% in 1973 to 28% in 2015. Migrant women are at increased risk of adverse pregnancy outcomes as low birth weight, infant small for gestational age , congenital malformations, stillbirth, neonatal morbidity and mortality and also obstetric interventions, such as induction of labour and caesarean section. Unfamiliarity with the health care system, language barriers, knowledge gaps and cultural issues are all obstacles that play a vital role in migrant women deprivation from achieving the standard maternal health care.
Migrant women have shown to consistently rate their maternity care more negatively in contrast with Swedish women, mainly due to lack of knowledge on how Swedish health care system is functioning and providing care which consequently cause communication difficulties, in addition to discrimination and prejudicial staff attitudes. Migrant women reported being left alone in labour, and feeling fearful, insecure and unsupported. Factors to be targeted to improve experiences of care and pregnancy outcomes include; breaking down language barriers and bridging cultural gaps, increasing familiarity with and enhancing understanding of Swedish maternity care, and empowering women's sense of safety and confidence in giving birth.
In Sweden, migration of women of childbearing age has increased most rapidly from Somalia and from a number of Arabic-speaking countries and also Eritrea and Russia. Somali women are known to be at highest risk of perinatal morbidity and mortality, they have problems engaging with Swedish antenatal care and because of communication and language barriers they reported to have the poorer experiences of care regarding labour and birth. Like Somali-women, many Arabic-speaking and Tigrinya-speaking women (from Eritrea) have relocated in Sweden after traumatic experiences of war and conflict. They, and the Russian women, constitute a growing group of women giving birth in Sweden with little knowledge of how Swedish maternity care operates and facing major communication barriers.
One initiative that has addressed communication problems between migrant women and the caregivers throughout childbirth was to provide language assistance and labour support , the Community Based Doula (Doula och kulturtolk) Project. CBDs are bilingual women from migrant communities trained by expert midwives to provide support for migrant women in labour and birth. CBDs meet twice with the migrant women prior to the birth, accompany her throughout the labour and provide emotional, physical support and communication; and language assistance; they meet again for follow up twice after the childbirth. Two small qualitative evaluations, conducted in the early years of the program, indicate high levels of satisfaction among supported women and midwives.
Current evidence supports the potential for CBDs to play an important role in improving continuity for migrant women during labour and birth, enhancing their experiences of birth and of care, as improving their pregnancy outcomes. Good physical and emotional support in labour is known to improve a range of outcomes; greater maternal satisfaction with care, less use of analgesia, shorter labours, lower rates of caesarean section and more spontaneous vaginal birth - with no adverse effects for women or infants.
Worldwide, no randomised controlled trials of doula support for migrant women have been reported, though two US non-randomised studies are relevant. One evaluated a hospital-based doula service provided to 123 of 348 Somali women giving birth in the study period. Lower rates of caesarean section (17% vs 26%) and greater satisfaction with care were found among the doula-supported Somali women17. Staff also felt more confident to care for Somali women when an English-speaking Somali doula was present. A second retrospective cohort study (n=11 471) evaluated a community doula program in an urban, culturally diverse setting and found a small but statistically significant reduction in caesarean section among women cared for by a midwife and a doula, compared with a midwife alone (15% vs 18%)18. Studies of midwives' views of working alongside labour companions have been positive14, 18.
In the Swedish setting, more robust and specific evidence is needed to support decisions whether to implement CBDs for migrant women at large-scale or not. Therefore, to evaluate the effectiveness of doula support to Somali, Eritrean, Arabic and Russian-speaking migrants we will here conduct a randomized controlled trial in Stockholm.
Aim To evaluate the effectiveness of community-based doula support for improving the intrapartum care experiences and postnatal wellbeing of Somali, Eritrean, Arabic and Russian-speaking migrant women giving birth in Stockholm.
Hypotheses
- That women randomised to receive CBD support in labour will rate their care for labour and birth more highly and have better emotional wellbeing (lower mean scores on the Edinburgh Postnatal Depression Scale) two months after birth than women allocated to standard care.
- That midwives and obstetricians caring for women randomised to receive CBD support will rate their provision of care more positively than when caring for women not supported.
Methods We plan a randomised controlled trial as a prospective evaluation of CBD support for migrant women in Stockholm, something not achieved when the original CBD program commenced in Gothenburg in 2008. The proposed trial will provide further and more rigorous evidence about the effectiveness of CBDs for improving migrant women's experiences of care and ultimately pregnancy outcomes for both mothers and infants. The study is designed to meet the CONSORT guidelines for reporting of randomised trials16 and will be registered in Clinical Trials.
Participants Migrant women from Somali, Tigrinya, Arabic and Russian-speaking countries will be recruited.
Inclusion criteria: Nulliparous and multiparous pregnant women between 25-36 weeks gestation, who are 18 years or older and from Somali-, Arabic-, Russian- and Tigrinya-speaking countries with no contra-indications for vaginal birth and cannot communicate fluently in Swedish.
Exclusion criteria: Women <18 years or women for whom a caesarean birth is planned and women not consenting to access to their birth records.
Recruitment: All Somali-, Arabic-, Russian and Tigrinya-speaking women cover the inclusion criteria and will participate in the study. They will be recruited with the assistance of interpreters during antenatal care visits between 25 and 36 weeks gestation.
Intervention - Community Based Doulas support Women allocated to receive CBD support will be contacted by an either a Somali, Arabic-, Russian- or Tigrinya-speaking CBD as appropriate, and arrangements made for them to meet twice prior to the birth to get to know each other and discuss the woman's wishes regarding support in labour and what the CBD can offer. Each woman will then contact her CBD when she goes into labour and the CBD will attend hospital with her and stay with her throughout her labour and birth, in addition to any other support people she may have, such as her partner.
CBDs will be recruited, trained and employed by non-profit organization MIRA, using well-tested processes. A total of 10 CBDs will be employed for the four migrant groups, ensuring the possibility of back-up when needed. Training content will cover the physiology of childbirth and strategies for providing effective continuous support in labour, as well as practical strategies for helping with communication/interpreting to enhance communication between women and midwives and discussion of CBD roles and boundaries. CBDs will be employed on an hourly basis to enable flexibility in timely provision of support to women in labour. Support for CBDs will be provided by an experienced midwife.
Comparison - standard intrapartum care Women allocated to the comparison arm of the trial will receive standard intrapartum care as provided at their chosen hospital of birth.
Women partner and/or other support people to accompany throughout her childbirth will be allowed, regardless of their trial allocation.
Randomisation and blinding Women will be randomly allocated to the intervention or control group utilising a computerised randomisation schedule. The randomisation ratio will be 1:1, CBD support to usual care, with block sizes of 4 or 6 distributed randomly. Allocations will be prepared in sealed, opaque envelopes accessible in a central location for antenatal recruiting midwives to access. Participants cannot be blinded in this study, however data collection and analysis will be undertaken blinded to group allocation.
Primary outcomes Women's ratings of care for labour and birth and maternal emotional wellbeing. Single item question from the Migrant Friendly Maternity Care Questionnaire (MFMCQ) will be used to assess women's ratings of care the Edinburgh Postnatal Depression Scale (the EPDS) will be used to assess maternal wellbeing.
Secondary outcomes Epidural analgesia, length of labour from admission and mode of birth. Data will be retrieved from hospital patient records will enable assessment of birth outcomes.
Data collection Trained bilingual researcher and research assistants will collect data on women's experiences of care by telephone or face-to-face interviews as appropriate, conducted at base-line and two months after birth. Birth outcome data for all trial participants will be extracted from patient records.
Sample size To detect an increase in women's ratings of intrapartum care from an expected 30% rating care as very good among those receiving usual care (based on estimates from studies of migrant women not fluent in the host country language) 22-24 to 53% in those receiving CBD support, (equal to Swedish speaking women in a national population based study) with 80% power and an alpha of 20%, 69 women in each group are needed. To have similar power to detect differences in mean scores on the Edinburgh Postnatal Depression Scale (a hypothesised reduction from a mean of 8.0 in the comparison group - similar to that found in studies of migrant women, to 6.0 in the intervention group - similar to that found in Swedish population-based studies), 63 women are required in each arm. Allowing for 20% loss to follow-up at the time of follow-up data collection with women two months postpartum, we expect to have outcome data on views of care and depressive symptoms for at least 100 women in each trial arm.
Statistical analysis First step of analysis will check the comparability of the groups, then the intervention group will be compared with the control group testing trial hypotheses and using intention to treat analyses. Odds ratios and 95% confidence intervals will then be estimated. If there are baseline differences on key participant characteristics (such as age, marital status, and medical conditions) between trial arms, logistic regression analyses will be performed adjusting for these differences. Comparison of means will be undertaken using t-tests where data are normally distributed, or medians compared using Mann-Whitney U tests used if not.
- Being tested
- Community-based doula support for labour, Standard labour support
- Medical subject headings
- Labor Pain, Consumer Behavior, Language
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Community-based doula support for labourOther
CBDs will be recruited, trained and employed by non-profit organization MIRA. Women allocated to receive CBD support will be contacted by an either a Somali, Arabic-, Russian- or Tigrinya-speaking CBD as appropriate, and arrangements made for them to meet twice prior to the birth to get to know each other and discuss the woman's wishes regarding support in labour and what the CBD can offer. Each woman will then contact her CBD when she goes into labour and the CBD will attend hospital with her and stay with her throughout her labour and birth, in addition to any other support people she may have, such as her partner.
Standard labour supportBehavioural
Standard labour support by health care providers only. Women allocated to the comparison arm of the trial will receive standard intrapartum care as provided at their chosen hospital of birth. That is emotional, information and instrumental support from a helping nurse or a midwife or in some cases a doctor. The support includes caring actions, such as comforting, massage, information and presence.
Note: Women partner and/or other support people to accompany throughout her childbirth will be allowed, regardless of their trial allocation.
| Study group | Role | What they receive |
|---|---|---|
| Community-based doula support for labour | Experimental | Women will receive support from a Community-based doula (CBD) plus standard labour support. Women will meet twice with the CBD prior to the birth to get to know each other and discuss the woman's wishes regarding support in labour and what the CBD can offer. The CBD will then stay with her throughout her labour and birth and support her with interpretation/Communication with the staff and emotional and instrumental support. The CBD-support will be in addition to any other support people she may have, such as her partner.
Note: Women partner and/or other support people to accompany throughout her childbirth will be allowed, regardless of their trial allocation.
CBDs will be recruited, trained and employed by non-profit organization MIRA, using well-tested processes. Receives: Other: Community-based doula support for labour; Behavioral: Standard labour support |
| Standard labour support | Active comparator | Standard labour support by health care providers only. Women allocated to the comparison arm of the trial will receive standard intrapartum care as provided at their chosen hospital of birth. That is emotional, information and instrumental support from a helping nurse or a midwife or in some cases a doctor. The support includes caring actions, such as comforting, massage, information and presence.
Note: Women partner and/or other support people to accompany throughout her childbirth will be allowed, regardless of their trial allocation. Receives: Other: Community-based doula support for labour; Behavioral: Standard labour support |
What is being measured
The primary outcome is the main question the study is designed to answer.
Maternal wellbeing
Maternal wellbeing as measured with the Edinburgh Postnatal Depression Scale (EPDS) (comparisons of mean values)
Measured: 6-8 weeks post partum
Women's overall ratings of labour care
Single item question:In general, were you happy with the healthcare you received? Very happy to No, not so happy.
Measured: 6-8 weeks post partum
Secondary outcomes (8)
Experience of birth
Single-item question measuring experience of giving birth on a five point scale
Measured: 6-8 weeks postpartum
Epidural analgesia
prospectively collected data during labour
Measured: Immediately after the birth
Length of labour
From admission to birth of the baby
Measured: Immediately after the birth
Mode of birth
Spontanous vaginal, instrumental vaginal or cesarean section
Measured: Immediately after the birth
Apgar score
5 items (Skin color, pulse rate, reflex irritability grimace, activity, respiratory effort) using a 0-2 scale for assessment of infant Health with total sum 10 wich is perfect
Measured: 5 minutes after the birth
Satisfaction with labour support
Overall, what do you think about all the support you received during childbirth? Very happy to Not so happy (5-response scale)
Measured: 6-8 weeks postpartum
Overall birth experience
Single item: What was your overall experience of giving birth? From very positive to very negative
Measured: 6-8 weeks postpartum
Neonatal intensive care
Transfer to NICO according to patient record
Measured: Within 7 days after birth
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Mar 2018
- Study start10 Mar 2018
- Primary completion5 May 2020
- Study completion5 May 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Labor PainStudies of the same condition, open and under way.
- More trials run by Karolinska InstitutetThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 164 participants (actual)
Sponsor and investigators
- Lead sponsor
- Karolinska Institutet
- Sponsor type
- University, hospital or other
- Collaborators
- Region Stockholm
- Responsible party
- Principal investigator, Erica Schytt, Karolinska Institutet
- Investigators
- Erica Schytt, Professor, Principal investigator, Karolinska Institutet
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03461640
- Sponsor's protocol ID
- K63135016
- Status last verified
- Oct 2020
- First submitted
- 23 Feb 2018
- Last updated
- 2 Nov 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Not included in the ethical approval
Publications
Schytt E, Wahlberg A, Eltayb A, Tsekhmestruk N, Small R, Lindgren H. Community-based bilingual doula support during labour and birth to improve migrant women's intrapartum care experiences and emotional well-being-Findings from a randomised controlled trial in Stockholm, Sweden [NCT03461640]. PLoS One. 2022 Nov 18;17(11):e0277533. doi: 10.1371/journal.pone.0277533. eCollection 2022.
PubMed 36399476Schytt E, Wahlberg A, Eltayb A, Small R, Tsekhmestruk N, Lindgren H. Community-based doula support for migrant women during labour and birth: study protocol for a randomised controlled trial in Stockholm, Sweden (NCT03461640). BMJ Open. 2020 Feb 18;10(2):e031290. doi: 10.1136/bmjopen-2019-031290.
PubMed 32075823
Study at a glance
From the registry record, last updated by the sponsor on 2 Nov 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Community Based Doulas for Migrant Women in Labour and Birth in Sweden - a Randomised Controlled Trial
- ClinicalTrials.gov ID
- NCT03461640
- Acronym / sponsor ID
- K63135016
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 164 participants (actual)
- Lead sponsor
- Karolinska InstitutetUniversity, hospital or other
- Collaborators
- Region Stockholm
- Study start
- 10 Mar 2018 (actual)
- Primary completion
- 5 May 2020 (actual)
- Study completion
- 5 May 2020 (actual)
- First posted
- 12 Mar 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
One initiative to address communication problems between migrant women not fluent in Swedish and caregivers throughout childbirth is to provide language assistance, cultural interpretation and labour support to the woman through Community Based Doulas (CBDs). CBDs are bilingual women from migrant communities trained by midwives to provide cultural, language and labour support to migrant women throughout their labour and birth.
The study will evaluate the effectiveness of community-based doula support for improving the intrapartum care experiences and postnatal wellbeing of Somali-, Tigrinya -, Arabic- and Russian-speaking migrant women giving birth in Stockholm, Sweden.
The randomisation ratio will be 1:1; CBD support in addition to standard intrapartum care or standard intrapartum care. Women allocated to receive CBD support in addition to standard intrapartum care (intervention group), will be contacted by a Somali, Arabic-, Russian- or Tigrinya-speaking CBD as appropriate, and arrangements will be made for the doula and the women to meet twice prior to the birth to get to know each other and discuss the woman's wishes regarding support in labour and what the CBD can offer. Each woman will then contact her CBD when she goes into labour and the CBD will attend hospital with her and stay with her throughout labour and birth, in addition to any other support people she may have, such as her partner. Women allocated to the comparison arm of the trial will receive standard intrapartum care as provided at their chosen hospital of birth.
The hypothesis is that women randomised to receive CBD support in labour will rate their care for labour and birth more highly and have better emotional wellbeing (lower mean scores on the Edinburgh Postnatal Depression Scale) two months after birth than women allocated to standard care.
Detailed description
In Sweden, the proportion of births to migrant women has more than doubled over the last four decades, from 10% in 1973 to 28% in 2015. Migrant women are at increased risk of adverse pregnancy outcomes as low birth weight, infant small for gestational age , congenital malformations, stillbirth, neonatal morbidity and mortality and also obstetric interventions, such as induction of labour and caesarean section. Unfamiliarity with the health care system, language barriers, knowledge gaps and cultural issues are all obstacles that play a vital role in migrant women deprivation from achieving the standard maternal health care.
Migrant women have shown to consistently rate their maternity care more negatively in contrast with Swedish women, mainly due to lack of knowledge on how Swedish health care system is functioning and providing care which consequently cause communication difficulties, in addition to discrimination and prejudicial staff attitudes. Migrant women reported being left alone in labour, and feeling fearful, insecure and unsupported. Factors to be targeted to improve experiences of care and pregnancy outcomes include; breaking down language barriers and bridging cultural gaps, increasing familiarity with and enhancing understanding of Swedish maternity care, and empowering women's sense of safety and confidence in giving birth.
In Sweden, migration of women of childbearing age has increased most rapidly from Somalia and from a number of Arabic-speaking countries and also Eritrea and Russia. Somali women are known to be at highest risk of perinatal morbidity and mortality, they have problems engaging with Swedish antenatal care and because of communication and language barriers they reported to have the poorer experiences of care regarding labour and birth. Like Somali-women, many Arabic-speaking and Tigrinya-speaking women (from Eritrea) have relocated in Sweden after traumatic experiences of war and conflict. They, and the Russian women, constitute a growing group of women giving birth in Sweden with little knowledge of how Swedish maternity care operates and facing major communication barriers.
One initiative that has addressed communication problems between migrant women and the caregivers throughout childbirth was to provide language assistance and labour support , the Community Based Doula (Doula och kulturtolk) Project. CBDs are bilingual women from migrant communities trained by expert midwives to provide support for migrant women in labour and birth. CBDs meet twice with the migrant women prior to the birth, accompany her throughout the labour and provide emotional, physical support and communication; and language assistance; they meet again for follow up twice after the childbirth. Two small qualitative evaluations, conducted in the early years of the program, indicate high levels of satisfaction among supported women and midwives.
Current evidence supports the potential for CBDs to play an important role in improving continuity for migrant women during labour and birth, enhancing their experiences of birth and of care, as improving their pregnancy outcomes. Good physical and emotional support in labour is known to improve a range of outcomes; greater maternal satisfaction with care, less use of analgesia, shorter labours, lower rates of caesarean section and more spontaneous vaginal birth - with no adverse effects for women or infants.
Worldwide, no randomised controlled trials of doula support for migrant women have been reported, though two US non-randomised studies are relevant. One evaluated a hospital-based doula service provided to 123 of 348 Somali women giving birth in the study period. Lower rates of caesarean section (17% vs 26%) and greater satisfaction with care were found among the doula-supported Somali women17. Staff also felt more confident to care for Somali women when an English-speaking Somali doula was present. A second retrospective cohort study (n=11 471) evaluated a community doula program in an urban, culturally diverse setting and found a small but statistically significant reduction in caesarean section among women cared for by a midwife and a doula, compared with a midwife alone (15% vs 18%)18. Studies of midwives' views of working alongside labour companions have been positive14, 18.
In the Swedish setting, more robust and specific evidence is needed to support decisions whether to implement CBDs for migrant women at large-scale or not. Therefore, to evaluate the effectiveness of doula support to Somali, Eritrean, Arabic and Russian-speaking migrants we will here conduct a randomized controlled trial in Stockholm.
Aim To evaluate the effectiveness of community-based doula support for improving the intrapartum care experiences and postnatal wellbeing of Somali, Eritrean, Arabic and Russian-speaking migrant women giving birth in Stockholm.
Hypotheses
- That women randomised to receive CBD support in labour will rate their care for labour and birth more highly and have better emotional wellbeing (lower mean scores on the Edinburgh Postnatal Depression Scale) two months after birth than women allocated to standard care.
- That midwives and obstetricians caring for women randomised to receive CBD support will rate their provision of care more positively than when caring for women not supported.
Methods We plan a randomised controlled trial as a prospective evaluation of CBD support for migrant women in Stockholm, something not achieved when the original CBD program commenced in Gothenburg in 2008. The proposed trial will provide further and more rigorous evidence about the effectiveness of CBDs for improving migrant women's experiences of care and ultimately pregnancy outcomes for both mothers and infants. The study is designed to meet the CONSORT guidelines for reporting of randomised trials16 and will be registered in Clinical Trials.
Participants Migrant women from Somali, Tigrinya, Arabic and Russian-speaking countries will be recruited.
Inclusion criteria: Nulliparous and multiparous pregnant women between 25-36 weeks gestation, who are 18 years or older and from Somali-, Arabic-, Russian- and Tigrinya-speaking countries with no contra-indications for vaginal birth and cannot communicate fluently in Swedish.
Exclusion criteria: Women <18 years or women for whom a caesarean birth is planned and women not consenting to access to their birth records.
Recruitment: All Somali-, Arabic-, Russian and Tigrinya-speaking women cover the inclusion criteria and will participate in the study. They will be recruited with the assistance of interpreters during antenatal care visits between 25 and 36 weeks gestation.
Intervention - Community Based Doulas support Women allocated to receive CBD support will be contacted by an either a Somali, Arabic-, Russian- or Tigrinya-speaking CBD as appropriate, and arrangements made for them to meet twice prior to the birth to get to know each other and discuss the woman's wishes regarding support in labour and what the CBD can offer. Each woman will then contact her CBD when she goes into labour and the CBD will attend hospital with her and stay with her throughout her labour and birth, in addition to any other support people she may have, such as her partner.
CBDs will be recruited, trained and employed by non-profit organization MIRA, using well-tested processes. A total of 10 CBDs will be employed for the four migrant groups, ensuring the possibility of back-up when needed. Training content will cover the physiology of childbirth and strategies for providing effective continuous support in labour, as well as practical strategies for helping with communication/interpreting to enhance communication between women and midwives and discussion of CBD roles and boundaries. CBDs will be employed on an hourly basis to enable flexibility in timely provision of support to women in labour. Support for CBDs will be provided by an experienced midwife.
Comparison - standard intrapartum care Women allocated to the comparison arm of the trial will receive standard intrapartum care as provided at their chosen hospital of birth.
Women partner and/or other support people to accompany throughout her childbirth will be allowed, regardless of their trial allocation.
Randomisation and blinding Women will be randomly allocated to the intervention or control group utilising a computerised randomisation schedule. The randomisation ratio will be 1:1, CBD support to usual care, with block sizes of 4 or 6 distributed randomly. Allocations will be prepared in sealed, opaque envelopes accessible in a central location for antenatal recruiting midwives to access. Participants cannot be blinded in this study, however data collection and analysis will be undertaken blinded to group allocation.
Primary outcomes Women's ratings of care for labour and birth and maternal emotional wellbeing. Single item question from the Migrant Friendly Maternity Care Questionnaire (MFMCQ) will be used to assess women's ratings of care the Edinburgh Postnatal Depression Scale (the EPDS) will be used to assess maternal wellbeing.
Secondary outcomes Epidural analgesia, length of labour from admission and mode of birth. Data will be retrieved from hospital patient records will enable assessment of birth outcomes.
Data collection Trained bilingual researcher and research assistants will collect data on women's experiences of care by telephone or face-to-face interviews as appropriate, conducted at base-line and two months after birth. Birth outcome data for all trial participants will be extracted from patient records.
Sample size To detect an increase in women's ratings of intrapartum care from an expected 30% rating care as very good among those receiving usual care (based on estimates from studies of migrant women not fluent in the host country language) 22-24 to 53% in those receiving CBD support, (equal to Swedish speaking women in a national population based study) with 80% power and an alpha of 20%, 69 women in each group are needed. To have similar power to detect differences in mean scores on the Edinburgh Postnatal Depression Scale (a hypothesised reduction from a mean of 8.0 in the comparison group - similar to that found in studies of migrant women, to 6.0 in the intervention group - similar to that found in Swedish population-based studies), 63 women are required in each arm. Allowing for 20% loss to follow-up at the time of follow-up data collection with women two months postpartum, we expect to have outcome data on views of care and depressive symptoms for at least 100 women in each trial arm.
Statistical analysis First step of analysis will check the comparability of the groups, then the intervention group will be compared with the control group testing trial hypotheses and using intention to treat analyses. Odds ratios and 95% confidence intervals will then be estimated. If there are baseline differences on key participant characteristics (such as age, marital status, and medical conditions) between trial arms, logistic regression analyses will be performed adjusting for these differences. Comparison of means will be undertaken using t-tests where data are normally distributed, or medians compared using Mann-Whitney U tests used if not.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Community-based doula support for labour | Experimental | Other: Community-based doula support for labour, Behavioral: Standard labour supportWomen will receive support from a Community-based doula (CBD) plus standard labour support. Women will meet twice with the CBD prior to the birth to get to know each other and discuss the woman's wishes regarding support in labour and what the CBD can offer. The CBD will then stay with her throughout her labour and birth and support her with interpretation/Communication with the staff and emotional and instrumental support. The CBD-support will be in addition to any other support people she may have, such as her partner. Note: Women partner and/or other support people to accompany throughout her childbirth will be allowed, regardless of their trial allocation. CBDs will be recruited, trained and employed by non-profit organization MIRA, using well-tested processes. |
| Standard labour support | Active comparator | Other: Community-based doula support for labour, Behavioral: Standard labour supportStandard labour support by health care providers only. Women allocated to the comparison arm of the trial will receive standard intrapartum care as provided at their chosen hospital of birth. That is emotional, information and instrumental support from a helping nurse or a midwife or in some cases a doctor. The support includes caring actions, such as comforting, massage, information and presence. Note: Women partner and/or other support people to accompany throughout her childbirth will be allowed, regardless of their trial allocation. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Nulliparous and multiparous pregnant women
- 25-36 weeks gestation
- Somali-, Arabic-, Russian- or Tigrinya-speaking
- Cannot communicate fluently in Swedish
- No contra-indications for vaginal birth
Key exclusion criteria (3 listed)
- Planned caesarean birth
- Not consenting to access to their birth records
- 17 years old or younger
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Community-based doula support for labourCBDs will be recruited, trained and employed by non-profit organization MIRA. Women allocated to receive CBD support will be contacted by an either a Somali, Arabic-, Russian- or Tigrinya-speaking CBD as appropriate, and arrangements made for them to meet twice prior to the birth to get to know each other and discuss the woman's wishes regarding support in labour and what the CBD can offer. Each woman will then contact her CBD when she goes into labour and the CBD will attend hospital with her and stay with her throughout her labour and birth, in addition to any other support people she may have, such as her partner. | Other | Community-based doula support for labour, Standard labour support |
| Standard labour supportStandard labour support by health care providers only. Women allocated to the comparison arm of the trial will receive standard intrapartum care as provided at their chosen hospital of birth. That is emotional, information and instrumental support from a helping nurse or a midwife or in some cases a doctor. The support includes caring actions, such as comforting, massage, information and presence. Note: Women partner and/or other support people to accompany throughout her childbirth will be allowed, regardless of their trial allocation. | Behavioural | Community-based doula support for labour, Standard labour support |
Primary outcome
Maternal wellbeing
Time frame: 6-8 weeks post partum
Maternal wellbeing as measured with the Edinburgh Postnatal Depression Scale (EPDS) (comparisons of mean values)
Women's overall ratings of labour care
Time frame: 6-8 weeks post partum
Single item question:In general, were you happy with the healthcare you received? Very happy to No, not so happy.
8 secondary outcomes
Experience of birth
Time frame: 6-8 weeks postpartum
Epidural analgesia
Time frame: Immediately after the birth
Length of labour
Time frame: Immediately after the birth
Mode of birth
Time frame: Immediately after the birth
Apgar score
Time frame: 5 minutes after the birth
Satisfaction with labour support
Time frame: 6-8 weeks postpartum
Overall birth experience
Time frame: 6-8 weeks postpartum
Neonatal intensive care
Time frame: Within 7 days after birth
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Nov 2020.
- Derived from this study: PubMed 36399476Schytt E, Wahlberg A, Eltayb A, Tsekhmestruk N, Small R, Lindgren H. Community-based bilingual doula support during labour and birth to improve migrant women's intrapartum care experiences and emotional well-being-Findings from a randomised controlled trial in Stockholm, Sweden [NCT03461640]. PLoS One. 2022 Nov 18;17(11):e0277533. doi: 10.1371/journal.pone.0277533. eCollection 2022.
- Derived from this study: PubMed 32075823Schytt E, Wahlberg A, Eltayb A, Small R, Tsekhmestruk N, Lindgren H. Community-based doula support for migrant women during labour and birth: study protocol for a randomised controlled trial in Stockholm, Sweden (NCT03461640). BMJ Open. 2020 Feb 18;10(2):e031290. doi: 10.1136/bmjopen-2019-031290.
- Individual participant dataSharing planned: No. Not included in the ethical approval
Related trials for Labor Pain
Recruiting
The Effect Of Partner-Assısted Rebozo Technıque On Labor Paın And Satısfactıon In Prımary Pregnant Women
Labor Pains
RecruitingPhase 4
Analgesic Efficacy and Obstetric Effects of Tramadol, Paracetamol and Placebo in Active Labor
Labor Pain
Not yet recruiting
Pre-Examination Reflexology for Anxiety and Pain During Pelvic Examination
Anxiety
Recruiting
Pain Neuroscience-Based Education for Labor Pain in Pregnant Women
Labor Pain and Anxiety
Recruiting
The Effect of Breast Milk, 10% and 20% Dextrose on Pain and Physiological Variables During Heel Puncture in Infants
Newborn Care, Pain Management
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Erica Schytt, Professor principal investigator
Karolinska Institutet
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Community-based doula support for labour and Standard labour support in people with Labor Pain and Satisfaction, Consumer, run by Karolinska Institutet at 1 site in Sweden.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Maternal wellbeing (time frame: 6-8 weeks post partum). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03461640, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2020.